» Articles » PMID: 35664958

Effect of Ancient Khorasan Wheat on Gut Microbiota, Inflammation, and Short-chain Fatty Acid Production in Patients with Fibromyalgia

Abstract

Background: Fibromyalgia (FM) syndrome is mainly characterized by widespread pain, sleeping disorders, fatigue, and cognitive dysfunction. In many cases, gastrointestinal distress is also reported, suggesting the potential pathogenic role of the gut microbiota (GM). The GM is deeply influenced by several environmental factors, especially the diet, and recent findings highlighted significant symptom improvement in FM patients following various nutritional interventions such as vegetarian diet, low-fermentable oligosaccharides, disaccharides, monosaccharides, and polyols based diets, gluten-free diet, and especially an ancient grain supplementation. In particular, a recent study reported that a replacement diet with ancient Khorasan wheat led to an overall improvement in symptom severity of FM patients.

Aim: To examine the effects of ancient Khorasan wheat on the GM, inflammation, and short-chain fatty acid production in FM patients.

Methods: After a 2-wk run-in period, 20 FM patients were enrolled in this randomized, double-blind crossover trial. In detail, they were assigned to consume either Khorasan or control wheat products for 8 wk and then, following an 8-wk washout period, crossed. Before and after treatments, GM characterization was performed by 16S rRNA sequencing while the fecal molecular inflammatory response and the short-chain fatty acids (SCFAs) were respectively determined with the Luminex MAGPIX detection system and a mass chromatography-mass spectrometry method.

Results: The Khorasan wheat replacement diet, in comparison with the control wheat diet, had more positive effects on intestinal microbiota composition and on both the fecal immune and SCFAs profiles such as the significant increase of butyric acid levels ( = 0.054), candidatus ( = 9.95e-06) and , and the reduction of ( = 4.97e-04). Moreover, the improvement of various FM symptoms along with the variation of some gut bacteria after the Khorasan wheat diet have been documented; in fact we reported positive correlations between and both Tiredness Symptoms Scale ( < 0.001) and Functional Outcome of Sleep Questionnaire ( < 0.05) scores, between and both Widespread Pain Index (WPI) + Symptom Severity scale (SS) ( < 0.05) and WPI ( < 0.05) scores, between candidatus and SS score ( < 0.05), and between and Sleep-Related and Safety Behaviour Questionnaire score ( < 0.05).

Conclusion: The replacement diet based on ancient Khorasan wheat results in beneficial GM compositional and functional modifications that positively correlate with an improvement of FM symptomatology.

Citing Articles

Role of Vitamin D Status and Alterations in Gut Microbiota Metabolism in Fibromyalgia-Associated Chronic Inflammatory Pain.

Saija C, Bertuccio M, Scoglio A, Macaione V, Cacciola F, Micalizzi G Biomedicines. 2025; 13(1).

PMID: 39857723 PMC: 11760899. DOI: 10.3390/biomedicines13010139.


Feeding gut microbes to nourish the brain: unravelling the diet-microbiota-gut-brain axis.

Schneider E, ORiordan K, Clarke G, Cryan J Nat Metab. 2024; 6(8):1454-1478.

PMID: 39174768 DOI: 10.1038/s42255-024-01108-6.


Effects of Prolonged Medical Fasting during an Inpatient, Multimodal, Nature-Based Treatment on Pain, Physical Function, and Psychometric Parameters in Patients with Fibromyalgia: An Observational Study.

Koppold D, Kandil F, Muller A, Guttler O, Steckhan N, Meiss S Nutrients. 2024; 16(7).

PMID: 38613092 PMC: 11013748. DOI: 10.3390/nu16071059.


Study protocol for FIBROKIT: a new tool for fibromyalgia diagnosis and patient follow-up.

Del Amo L, Duran-Gonzalez E, Ramirez-Tejero J, Martinez-Lara A, Cotan D Front Neurol. 2023; 14:1286539.

PMID: 38073622 PMC: 10710143. DOI: 10.3389/fneur.2023.1286539.


Can open label placebos improve pain and gluten tolerance via open label placebos in fibromyalgia patients? A study protocol for a randomised clinical trial in an outpatient centre.

Paschke L, Dreyer N, Worm M, Klinger R BMJ Open. 2023; 13(10):e074957.

PMID: 37865404 PMC: 10603456. DOI: 10.1136/bmjopen-2023-074957.


References
1.
Barandouzi Z, Lee J, Maas K, Starkweather A, Cong X . Altered Gut Microbiota in Irritable Bowel Syndrome and Its Association with Food Components. J Pers Med. 2021; 11(1). PMC: 7827153. DOI: 10.3390/jpm11010035. View

2.
Cenit M, Matzaraki V, Tigchelaar E, Zhernakova A . Rapidly expanding knowledge on the role of the gut microbiome in health and disease. Biochim Biophys Acta. 2014; 1842(10):1981-1992. DOI: 10.1016/j.bbadis.2014.05.023. View

3.
Uceyler N, Valenza R, Stock M, Schedel R, Sprotte G, Sommer C . Reduced levels of antiinflammatory cytokines in patients with chronic widespread pain. Arthritis Rheum. 2006; 54(8):2656-64. DOI: 10.1002/art.22026. View

4.
Littlejohn G, Guymer E . Key Milestones Contributing to the Understanding of the Mechanisms Underlying Fibromyalgia. Biomedicines. 2020; 8(7). PMC: 7400313. DOI: 10.3390/biomedicines8070223. View

5.
Peck M, Maram R, Mohamed A, Ochoa Crespo D, Kaur G, Ashraf I . The Influence of Pro-inflammatory Cytokines and Genetic Variants in the Development of Fibromyalgia: A Traditional Review. Cureus. 2020; 12(9):e10276. PMC: 7538208. DOI: 10.7759/cureus.10276. View